The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide
dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Perinatology
Collaborator:
National Council of Science and Technology, Mexico